Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Stockholders' Equity

v3.8.0.1
Note 10 - Stockholders' Equity
3 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
NOTE
10
 — STOCKHOLDERS’ EQUITY
 
Shares to be Issued
 
 
As of
March 31, 2018,
and
December 31, 2017,
there were
1,699,323
and
1,401,247
shares of common stock, respectively, whose issuance has been deferred under the terms of an employment agreements with the Chief Executive Officer, Chief Financial Officer and other employees of Milestone Scientific. Such shares will be issued to each such person upon termination of their employment. The number of shares was fixed at the date of grant and were fully vested upon grant date.
  
Shares Reserved for Future Issuance
 
As of
March 31, 2018,
and
December 31, 2017
there were
5,209,658
and
5,111,582
shares reserved for future issuance and
3,510,335,
and
3,710,335
shares underlying other stock options and warrants outstanding, respectively. At
March 31, 2018
and
December 31, 2017,
there were
1,699,323
shares and
1,401,247
shares, respectively, reserved for issuance in settlement of deferred compensation to officers of Milestone Scientific.